All lobbying filings

FORBES-TATE

Lobbying for WALGREENS CO. · An American company that operates as the second-largest pharmacy store chain.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 3

Health Issues

Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA certification process; Issues related to Pharmacy Benefit Managers.

Medicare/Medicaid

Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Pharmacy Benefit Managers.

Taxation/Internal Revenue Code

Issues related to corporate tax, net operating loss, EBITA/EBIDA.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.